Turkey
Denovo Biotechnology Inc. is a biotechnology startup founded in 2009 at Middle East Technical University Technopark in Turkey. The company specializes in R&D activities, providing consultancy services, and developing biotech test platforms. With a focus on DNA-based diagnostic products, Denovo aims to become a leading firm in Turkey and globally, reducing the country's dependence on advanced nations in the field of science.
Denovo has a strong track record in various biotech fields, with patents, articles, and Gen Bank entries to its name. The company's expertise spans diagnostic device manufacturing, PCR-based diagnostic kit development, nucleic acid isolation kit development, and nanoparticle synthesis. Their proficiency extends to oligonucleotide primer and probe design, recombinant protein production, and purification, adhering to current good manufacturing practices (cGMP) in their production processes.
As Denovo Biotechnology Inc. continues to expand its presence and influence in the Biotechnology, Deep Tech, and Life Sciences industries, its dedication to innovative R&D and goal of global leadership positions it as a promising investment opportunity, especially for venture capitalists seeking to support advancements in biotech and life sciences.